Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies
Acquisition of HIV while receiving LEN and resistance to LEN in the context of unrecognized HIV was rare but associated with the emergence of the N74D LEN resistance-associated substitution in this population.
Authors
- Lillian B. Brown (ORCID: https://orcid.org/0000-0003-1809-3762)
- Alexander Kintu (ORCID: https://orcid.org/0000-0003-3957-1487)
- Christoph C Carter (ORCID: https://orcid.org/0000-0001-7793-8011)
- Kristen Andreatta
- Stephanie Cox
- Christian Callebaut (ORCID: https://orcid.org/0000-0003-4721-2572)
- Matthew R. Hendricks
- Jiani Li (ORCID: https://orcid.org/0009-0002-5563-4505)
Institutions
- Gilead Sciences (United States) (US)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2025-10-18
- DOI
- https://doi.org/10.1093/infdis/jiaf533
- Citations
- 1
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.40